157 related articles for article (PubMed ID: 32301315)
1. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(690):756-757. PubMed ID: 32301315
[No Abstract] [Full Text] [Related]
2. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(689):704-705. PubMed ID: 32270942
[No Abstract] [Full Text] [Related]
3. Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E; Grant-Kels JM
J Am Acad Dermatol; 2020 Jul; 83(1):e33-e34. PubMed ID: 32283236
[No Abstract] [Full Text] [Related]
4. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
Malviya A
Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
[No Abstract] [Full Text] [Related]
5. The coronavirus outbreak could make it quicker and easier to trial drugs.
Ledford H
Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
[No Abstract] [Full Text] [Related]
6. Reactivation of COVID-19 pneumonia: A report of two cases.
Ravioli S; Ochsner H; Lindner G
J Infect; 2020 Aug; 81(2):e72-e73. PubMed ID: 32389787
[No Abstract] [Full Text] [Related]
7. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
8. Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
[No Abstract] [Full Text] [Related]
9. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
Taccone FS; Gorham J; Vincent JL
Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
[No Abstract] [Full Text] [Related]
10. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
Peschken CA
J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.
Scuccimarri R; Sutton E; Fitzcharles MA
J Rheumatol; 2020 Jun; 47(6):783-786. PubMed ID: 32241801
[No Abstract] [Full Text] [Related]
12. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
13. Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome.
Okour M; Al-Kofahi M; Austin D
J Pharmacokinet Pharmacodyn; 2020 Jun; 47(3):187-188. PubMed ID: 32405664
[No Abstract] [Full Text] [Related]
14. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19.
Kara E; Demirkan K; Unal S
Int J Antimicrob Agents; 2020 Sep; 56(3):106123. PubMed ID: 32738307
[No Abstract] [Full Text] [Related]
15. [Not Available].
Nau JY
Rev Med Suisse; 2020 Apr; 16(N° 691-2):876-877. PubMed ID: 32348059
[No Abstract] [Full Text] [Related]
16. Audio Interview: Studying Potential Covid-19 Therapies.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
[No Abstract] [Full Text] [Related]
17. [Not Available].
Nau JY
Rev Med Suisse; 2020 Jun; 16(697):1218-1219. PubMed ID: 32520464
[No Abstract] [Full Text] [Related]
18. Regulators split on antimalarials for COVID-19.
Jaffe S
Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
[No Abstract] [Full Text] [Related]
19. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
20. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB; Dash AP
Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]